Developing malaria vaccines that enhance immune response through T cells

Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines

NIH-funded research Seattle Children's Hospital · NIH-11010844

This study is looking at how to make better malaria vaccines by learning how certain immune cells react to the malaria parasite when it infects the liver, so we can help protect people from getting malaria more effectively.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital NIH-funded
Lab location1 site (Seattle, United States)
Project IDNIH-11010844 on NIH RePORTER

What this research studies

This research focuses on creating effective vaccines against malaria by understanding how certain immune cells, specifically CD8+ T cells, respond to liver stage infections caused by the malaria parasite. The team will investigate how different types of vaccines, including those that replicate in the liver, can stimulate a stronger immune response. By studying the timing and mechanisms of how liver-infected cells present antigens to T cells, the research aims to improve vaccine design for better protection against malaria.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk of malaria infection, particularly those living in endemic regions.

Not a fit: Patients who are not at risk of malaria or those who have already been vaccinated against malaria may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective malaria vaccines that provide long-lasting immunity.

How similar studies have performed: Previous research has shown promising results with similar vaccine approaches in animal models, indicating potential for success in human applications.

Where this research is happening

Seattle, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.